FREMANEZUMAB-VFRM

FREMANEZUMAB-VFRM was reported 11839 times

FREMANEZUMAB-VFRM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DEVICE AUDIO ISSUE 45 0.4167
1 INVOLUNTARY VOCALISATION 4 0.1379
2 STATUS MIGRAINOSUS 10 0.0621
3 PRIMARY STABBING HEADACHE 4 0.0563
4 HEMIPLEGIC MIGRAINE 14 0.0413
5 INJECTION SITE DISCHARGE 129 0.0240
6 FOETAL MONITORING ABNORMAL 4 0.0240
7 MEDICATION OVERUSE HEADACHE 16 0.0187
8 GASTROINTESTINAL MUCOSA HYPERAEMIA 5 0.0169
9 MIGRAINE WITHOUT AURA 5 0.0167
10 IMMEDIATE POST-INJECTION REACTION 17 0.0155
11 INCORRECT DOSE ADMINISTERED BY DEVICE 402 0.0153
12 ACCIDENTAL EXPOSURE TO PRODUCT 1501 0.0146
13 INJECTION SITE PLAQUE 3 0.0143
14 INJECTION SITE EXTRAVASATION 167 0.0135
15 DEVICE LEAKAGE 576 0.0133
16 HISTAMINE INTOLERANCE 3 0.0132
17 DEVICE ALARM ISSUE 24 0.0132
18 PHONOPHOBIA 6 0.0130
19 NEUROGENIC SHOCK 7 0.0129
20 INJECTION RELATED REACTION 21 0.0127
21 OCCIPITAL NEURALGIA 7 0.0124
22 INJECTION SITE OEDEMA 21 0.0122
23 MIGRAINE 1114 0.0117
24 INJECTION SITE HYPERSENSITIVITY 35 0.0112
25 ABORTION MISSED 14 0.0110
26 DUODENOGASTRIC REFLUX 3 0.0108
27 ANISOCORIA 4 0.0106
28 NEEDLE ISSUE 289 0.0099
29 DEVICE DELIVERY SYSTEM ISSUE 271 0.0099
30 DRUG DELIVERY SYSTEM ISSUE 19 0.0096
31 LOCAL REACTION 7 0.0094
32 INJECTION SITE RASH 290 0.0094
33 INJECTION SITE SCAR 26 0.0091
34 PRODUCT CLOSURE REMOVAL DIFFICULT 9 0.0088
35 NEEDLE FATIGUE 4 0.0088
36 INJECTION SITE CELLULITIS 16 0.0086
37 GASTROINTESTINAL MICROORGANISM OVERGROWTH 3 0.0085
38 ALLERGY TO METALS 5 0.0082
39 DEVICE DEFECTIVE 134 0.0077
40 HEMIPARAESTHESIA 3 0.0077
41 INJECTION SITE PRURITUS 511 0.0076
42 INJECTION SITE URTICARIA 184 0.0075
43 DEVICE MALFUNCTION 521 0.0074
44 ARTERY DISSECTION 3 0.0073
45 ADENOMYOSIS 4 0.0068
46 ENLARGED UVULA 3 0.0067
47 INJECTION SITE WARMTH 137 0.0067
48 EHLERS-DANLOS SYNDROME 3 0.0065
49 INJECTION SITE INFLAMMATION 32 0.0064
50 INJECTION SITE VESICLES 38 0.0063
51 PATIENT DISSATISFACTION WITH TREATMENT 12 0.0062
52 INJECTION SITE MASS 229 0.0062
53 THERAPEUTIC PRODUCT EFFECT VARIABLE 24 0.0062
54 JOB DISSATISFACTION 4 0.0062
55 INJECTION SITE SWELLING 462 0.0060
56 INJECTION SITE INDURATION 78 0.0060
57 MIGRAINE WITH AURA 16 0.0059
58 CLUSTER HEADACHE 8 0.0058
59 DRUG DOSE OMISSION BY DEVICE 455 0.0058
60 RETINAL VEIN THROMBOSIS 4 0.0057
61 EMERGENCY CARE 17 0.0056
62 INJECTION SITE INDENTATION 12 0.0055
63 INJECTION SITE ERYTHEMA 685 0.0055
64 CARDIOSPASM 3 0.0054
65 MATERNAL EXPOSURE TIMING UNSPECIFIED 20 0.0053
66 INJECTION SITE DISCOLOURATION 65 0.0052
67 PHARYNGEAL PARAESTHESIA 8 0.0050
68 INSURANCE ISSUE 76 0.0050
69 AURA 9 0.0048
70 FEAR OF INJECTION 34 0.0048
71 DEVICE DEPLOYMENT ISSUE 60 0.0047
72 BLOOD PRESSURE MEASUREMENT 3 0.0047
73 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 217 0.0046
74 ELECTRIC SHOCK SENSATION 13 0.0046
75 INJECTION SITE PARAESTHESIA 7 0.0046
76 INFUSION SITE URTICARIA 3 0.0045
77 INJECTION SITE REACTION 307 0.0045
78 INJECTION SITE PAIN 1358 0.0044
79 INCORRECT DOSE ADMINISTERED BY PRODUCT 7 0.0044
80 BRAIN FOG 68 0.0043
81 NEAR DEATH EXPERIENCE 14 0.0042
82 INJECTION SITE HYPOAESTHESIA 6 0.0042
83 THERAPEUTIC RESPONSE SHORTENED 136 0.0041
84 LACK OF INJECTION SITE ROTATION 7 0.0040
85 INABILITY TO AFFORD MEDICATION 39 0.0039
86 INJECTION SITE IRRITATION 49 0.0038
87 HYPERACUSIS 14 0.0038
88 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 5 0.0037
89 MAST CELL ACTIVATION SYNDROME 5 0.0036
90 DEVICE ISSUE 315 0.0035
91 CORONARY ARTERY DISSECTION 3 0.0035
92 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 59 0.0034
93 HEAD DISCOMFORT 60 0.0034
94 MENSTRUAL DISORDER 28 0.0034
95 INDURATION 6 0.0034
96 INJECTION SITE INFECTION 11 0.0033
97 THERAPEUTIC PRODUCT EFFECT DELAYED 15 0.0033
98 ANEURYSM RUPTURED 3 0.0033
99 INJECTION SITE DISCOMFORT 34 0.0032
100 TRICHORRHEXIS 9 0.0032
101 PHARYNGEAL SWELLING 31 0.0032
102 INAPPROPRIATE AFFECT 5 0.0032
103 ARNOLD-CHIARI MALFORMATION 3 0.0031
104 MOTION SICKNESS 6 0.0031
105 DEVICE DIFFICULT TO USE 200 0.0030
106 SINUS PAIN 7 0.0030
107 GASTRECTOMY 3 0.0030
108 IMPAIRED WORK ABILITY 63 0.0029
109 PRODUCT ADMINISTRATION INTERRUPTED 23 0.0029
110 INFUSION SITE DISCHARGE 5 0.0028
111 SLEEP DEFICIT 6 0.0028
112 VASCULAR INJURY 4 0.0028
113 INFUSION SITE MASS 3 0.0028
114 INJECTION SITE HAEMORRHAGE 219 0.0027
115 TONGUE BLISTERING 6 0.0027
116 IDIOPATHIC INTRACRANIAL HYPERTENSION 6 0.0027
117 PANIC REACTION 19 0.0026
118 INJECTION SITE BRUISING 209 0.0026
119 LIQUID PRODUCT PHYSICAL ISSUE 19 0.0026
120 ADMINISTRATION SITE PAIN 3 0.0026
121 CHEMICAL BURN 3 0.0026
122 CONCUSSION 20 0.0026
123 PANIC DISORDER 10 0.0026
124 NASAL SEPTUM DEVIATION 5 0.0026
125 DEVICE DISPENSING ERROR 3 0.0025
126 INJECTION SITE INJURY 14 0.0025
127 ENDOMETRIOSIS 12 0.0025
128 BEDRIDDEN 32 0.0024
129 PRODUCT SUPPLY ISSUE 17 0.0024
130 EAR SWELLING 5 0.0024
131 SLEEP TALKING 4 0.0024
132 INFUSION SITE IRRITATION 3 0.0023
133 THROAT TIGHTNESS 63 0.0023
134 HEAVY MENSTRUAL BLEEDING 20 0.0022
135 CHRONIC GASTRITIS 5 0.0022
136 CLUMSINESS 6 0.0022
137 PRODUCT COMMUNICATION ISSUE 19 0.0022
138 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 152 0.0021
139 TUNNEL VISION 4 0.0021
140 GLUTEN SENSITIVITY 3 0.0021
141 FACIAL PARALYSIS 18 0.0021
142 TENSION HEADACHE 9 0.0021
143 ADRENAL DISORDER 4 0.0021
144 PARAESTHESIA ORAL 30 0.0021
145 RHEUMATIC DISORDER 4 0.0021
146 NEGATIVE THOUGHTS 6 0.0020
147 NECK INJURY 6 0.0020
148 HAEMATOLOGICAL INFECTION 5 0.0020
149 ANAL ABSCESS 11 0.0020
150 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 4 0.0020
151 ALLERGIC REACTION TO EXCIPIENT 4 0.0020
152 PANIC ATTACK 73 0.0020
153 HANGOVER 7 0.0020
154 INTERMENSTRUAL BLEEDING 11 0.0020
155 EXPOSURE VIA SKIN CONTACT 51 0.0020
156 GENITAL HERPES 3 0.0020
157 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 346 0.0019
158 INJURY ASSOCIATED WITH DEVICE 39 0.0019
159 SENSITIVITY TO WEATHER CHANGE 10 0.0019
160 CEREBRAL DISORDER 14 0.0019
161 PHOTOPHOBIA 35 0.0019
162 DEREALISATION 4 0.0019
163 INFUSION SITE BRUISING 4 0.0019
164 HORMONE LEVEL ABNORMAL 9 0.0018
165 ANORGASMIA 5 0.0018
166 LIP BLISTER 5 0.0018
167 OLIGOMENORRHOEA 4 0.0018
168 ASTHENOPIA 10 0.0018
169 OTITIS MEDIA 6 0.0018
170 POOR QUALITY PRODUCT ADMINISTERED 19 0.0018
171 PRODUCT ADMINISTRATION ERROR 36 0.0018
172 DRUG EFFECT LESS THAN EXPECTED 26 0.0018
173 PRODUCT STORAGE ERROR 153 0.0017
174 BLEPHAROSPASM 11 0.0017
175 THERAPEUTIC PRODUCT EFFECT DECREASED 78 0.0017
176 POLYMENORRHOEA 6 0.0017
177 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 83 0.0017
178 DEPRESSIVE SYMPTOM 6 0.0017
179 NECK PAIN 95 0.0017
180 SKIN INFECTION 19 0.0017
181 IMPAIRED GASTRIC EMPTYING 23 0.0017
182 SUICIDAL BEHAVIOUR 7 0.0017
183 GESTATIONAL DIABETES 8 0.0017
184 IMPAIRED DRIVING ABILITY 19 0.0017
185 SWOLLEN TONGUE 52 0.0017
186 INCORRECT DRUG ADMINISTRATION RATE 7 0.0016
187 BODY TEMPERATURE ABNORMAL 3 0.0016
188 DISORGANISED SPEECH 3 0.0016
189 CEREBROSPINAL FLUID LEAKAGE 3 0.0016
190 RETINAL TEAR 4 0.0016
191 MATERNAL EXPOSURE BEFORE PREGNANCY 11 0.0016
192 VERTIGO 98 0.0016
193 PALPITATIONS 188 0.0016
194 EYELIDS PRURITUS 5 0.0016
195 PRODUCT USE COMPLAINT 25 0.0016
196 DERMATOMYOSITIS 4 0.0016
197 PRODUCT CONTAMINATION PHYSICAL 4 0.0016
198 THYROID MASS 6 0.0016
199 SKIN REACTION 22 0.0016
200 MOUTH SWELLING 9 0.0016
201 ABNORMAL UTERINE BLEEDING 4 0.0016
202 ALOPECIA 306 0.0016
203 PRODUCT TEMPERATURE EXCURSION ISSUE 8 0.0016
204 OROPHARYNGEAL DISCOMFORT 14 0.0015
205 CARDIAC FLUTTER 10 0.0015
206 CONVERSION DISORDER 3 0.0015
207 AUTOIMMUNE DISORDER 15 0.0015
208 POSTMENOPAUSAL HAEMORRHAGE 4 0.0015
209 NEURALGIA 37 0.0015
210 INFUSION SITE HAEMORRHAGE 5 0.0015
211 SKIN INJURY 5 0.0015
212 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 4 0.0015
213 CONSTIPATION 327 0.0015
214 FRUSTRATION TOLERANCE DECREASED 12 0.0015
215 NORMAL NEWBORN 8 0.0015
216 EAR DISCOMFORT 15 0.0015
217 IMPAIRED QUALITY OF LIFE 21 0.0015
218 SPINAL PAIN 17 0.0014
219 INFUSION SITE SWELLING 9 0.0014
220 DEVICE USE ISSUE 25 0.0014
221 FOOD ALLERGY 11 0.0014
222 ATTENTION DEFICIT HYPERACTIVITY DISORDER 6 0.0014
223 EYE CONTUSION 3 0.0014
224 MUSCLE FATIGUE 6 0.0014
225 THERMAL BURN 10 0.0014
226 URTICARIA 236 0.0014
227 GLOSSITIS 5 0.0014
228 OESOPHAGEAL STENOSIS 4 0.0014
229 SKIN WEEPING 5 0.0014
230 VITAMIN B12 DECREASED 4 0.0014
231 PERIPHERAL COLDNESS 19 0.0014
232 DRUG DELIVERY SYSTEM MALFUNCTION 7 0.0014
233 PERIPHERAL VASCULAR DISORDER 7 0.0014
234 ACCIDENT AT WORK 3 0.0014
235 BLINDNESS TRANSIENT 10 0.0014
236 TINNITUS 62 0.0013
237 INFECTIOUS MONONUCLEOSIS 3 0.0013
238 ACNE CYSTIC 4 0.0013
239 PRODUCT DOSE OMISSION ISSUE 390 0.0013
240 LOSS OF EMPLOYMENT 4 0.0013
241 CRANIOCEREBRAL INJURY 4 0.0013
242 ILLNESS 136 0.0013
243 BREAKTHROUGH PAIN 3 0.0013
244 BRAIN INJURY 13 0.0013
245 MUSCLE TIGHTNESS 21 0.0013
246 FORMICATION 9 0.0013
247 EXTRASYSTOLES 9 0.0013
248 INCORRECT DOSE ADMINISTERED 290 0.0013
249 HAND FRACTURE 9 0.0013
250 ADVERSE EVENT 117 0.0013
251 PRODUCT USE ISSUE 238 0.0013
252 DEVICE FAILURE 19 0.0012
253 SWELLING FACE 81 0.0012
254 HEADACHE 778 0.0012
255 SENSITIVE SKIN 9 0.0012
256 PSYCHIATRIC SYMPTOM 9 0.0012
257 SPINAL OPERATION 15 0.0012
258 CARTILAGE INJURY 3 0.0012
259 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 246 0.0012
260 DISABILITY 24 0.0012
261 HEMIPLEGIA 10 0.0012
262 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 22 0.0012
263 HYPOAESTHESIA ORAL 18 0.0012
264 PAROSMIA 9 0.0012
265 INTENTIONAL DOSE OMISSION 34 0.0012
266 CHEST DISCOMFORT 122 0.0012
267 MUSCLE TWITCHING 27 0.0012
268 IRRITABLE BOWEL SYNDROME 25 0.0012
269 THERAPEUTIC RESPONSE UNEXPECTED 52 0.0012
270 TACHYPHRENIA 4 0.0012
271 INTERCEPTED PRODUCT STORAGE ERROR 4 0.0011
272 FACIAL PAIN 10 0.0011
273 SENSORY LOSS 9 0.0011
274 SWELLING OF EYELID 7 0.0011
275 SYNCOPE 111 0.0011
276 HYPERAESTHESIA 9 0.0011
277 PRODUCT DOSE OMISSION IN ERROR 31 0.0011
278 HYPERSENSITIVITY 203 0.0011
279 FEEDING DISORDER 22 0.0011
280 EOSINOPHILIC OESOPHAGITIS 3 0.0011
281 ANGINA PECTORIS 31 0.0011
282 PRODUCT DISTRIBUTION ISSUE 10 0.0011
283 LIVE BIRTH 9 0.0011
284 SURGERY 63 0.0011
285 ABORTION SPONTANEOUS 43 0.0011
286 ROSACEA 5 0.0011
287 BURNING SENSATION 75 0.0011
288 SOMNAMBULISM 7 0.0011
289 WALKING AID USER 7 0.0011
290 ADVERSE REACTION 14 0.0011
291 PARALYSIS 15 0.0010
292 THROAT IRRITATION 47 0.0010
293 CONJUNCTIVAL HAEMORRHAGE 4 0.0010
294 POST-TRAUMATIC STRESS DISORDER 7 0.0010
295 SCRATCH 11 0.0010
296 FIBULA FRACTURE 3 0.0010
297 THYROID DISORDER 16 0.0010
298 ADVERSE DRUG REACTION 93 0.0010
299 PRODUCT LABEL ISSUE 7 0.0010
300 FIBROMYALGIA 25 0.0010
301 PRESYNCOPE 25 0.0010
302 FAECES HARD 4 0.0010
303 MUSCLE RUPTURE 4 0.0010
304 APHASIA 31 0.0010
305 POOR QUALITY SLEEP 22 0.0010
306 MIDDLE INSOMNIA 19 0.0010
307 VITREOUS FLOATERS 10 0.0010
308 SWELLING 95 0.0010
309 MUCOUS STOOLS 5 0.0010
310 ANXIETY 287 0.0010
311 DEVICE USE ERROR 35 0.0010
312 SYMPTOM RECURRENCE 6 0.0010
313 FEELING ABNORMAL 240 0.0010
314 BLEPHARITIS 4 0.0010
315 INTRACRANIAL ANEURYSM 4 0.0010
316 FEELING HOT 61 0.0010
317 TRIGEMINAL NEURALGIA 4 0.0010
318 SPEECH DISORDER 52 0.0010
319 ENURESIS 4 0.0010
320 SPINAL FUSION SURGERY 4 0.0010
321 BRAIN NEOPLASM 9 0.0010
322 HYPERSOMNIA 28 0.0010
323 SOCIAL PROBLEM 4 0.0010
324 DISTURBANCE IN ATTENTION 52 0.0010
325 THYROID FUNCTION TEST ABNORMAL 4 0.0010
326 PRURITUS 370 0.0010
327 GAIT INABILITY 32 0.0010
328 WEIGHT FLUCTUATION 10 0.0010
329 WEIGHT INCREASED 214 0.0010
330 SELF-INJURIOUS IDEATION 4 0.0010
331 INFUSION SITE PRURITUS 3 0.0009
332 SLEEP TERROR 4 0.0009
333 PHOTOPSIA 6 0.0009
334 INFUSION SITE ERYTHEMA 8 0.0009
335 LIP OEDEMA 4 0.0009
336 TONGUE DISCOMFORT 4 0.0009
337 FEELING DRUNK 7 0.0009
338 NYSTAGMUS 5 0.0009
339 ABNORMAL DREAMS 26 0.0009
340 SUPRAVENTRICULAR TACHYCARDIA 9 0.0009
341 INTERVERTEBRAL DISC DISORDER 4 0.0009
342 TEARFULNESS 4 0.0009
343 MUSCULOSKELETAL DISCOMFORT 16 0.0009
344 HEART RATE INCREASED 92 0.0009
345 SEIZURE 107 0.0009
346 ANTINUCLEAR ANTIBODY POSITIVE 3 0.0009
347 MONOPLEGIA 4 0.0009
348 PRODUCT PRESCRIBING ISSUE 20 0.0009
349 THERAPY CHANGE 9 0.0009
350 INTERVERTEBRAL DISC PROTRUSION 20 0.0009
351 DEAFNESS NEUROSENSORY 3 0.0009
352 IMMUNE SYSTEM DISORDER 12 0.0009
353 PARAESTHESIA 143 0.0009
354 COLD SWEAT 16 0.0009
355 CORONAVIRUS INFECTION 6 0.0009
356 DYSMENORRHOEA 12 0.0009
357 NERVOUSNESS 47 0.0009
358 ANAPHYLACTIC SHOCK 23 0.0009
359 DEPRESSED MOOD 47 0.0009
360 PERIORBITAL SWELLING 5 0.0009
361 PRODUCT PRESCRIBING ERROR 21 0.0009
362 HYPOAESTHESIA 131 0.0009
363 CHEST PAIN 162 0.0009
364 DERMATITIS ALLERGIC 11 0.0009
365 INJECTION SITE PAPULE 4 0.0009
366 COVID-19 153 0.0009
367 ABDOMINAL DISTENSION 91 0.0009
368 RESPIRATION ABNORMAL 6 0.0009
369 ANAPHYLACTIC REACTION 48 0.0009
370 FUNCTIONAL GASTROINTESTINAL DISORDER 3 0.0009
371 RASH PRURITIC 47 0.0009
372 BLOOD PRESSURE DIASTOLIC INCREASED 4 0.0009
373 VENTRICULAR EXTRASYSTOLES 9 0.0009
374 MATERNAL EXPOSURE DURING PREGNANCY 77 0.0009
375 HYPERVENTILATION 5 0.0009
376 INFLUENZA LIKE ILLNESS 71 0.0009
377 AORTIC STENOSIS 3 0.0009
378 INFUSION SITE PAIN 11 0.0009
379 FEELING OF BODY TEMPERATURE CHANGE 5 0.0009
380 CRYING 31 0.0009
381 PAPULE 6 0.0009
382 EYE PAIN 48 0.0008
383 UPPER-AIRWAY COUGH SYNDROME 7 0.0008
384 HAEMORRHAGE SUBCUTANEOUS 3 0.0008
385 HAEMORRHAGIC DIATHESIS 3 0.0008
386 APPENDICECTOMY 3 0.0008
387 EYE INFLAMMATION 8 0.0008
388 TASTE DISORDER 17 0.0008
389 ANKYLOSING SPONDYLITIS 11 0.0008
390 DIZZINESS 414 0.0008
391 TOOTHACHE 15 0.0008
392 VISUAL IMPAIRMENT 102 0.0008
393 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 5 0.0008
394 MAJOR DEPRESSION 6 0.0008
395 PIGMENTATION DISORDER 5 0.0008
396 SCOLIOSIS 5 0.0008
397 INFLAMMATORY MARKER INCREASED 4 0.0008
398 NEPHROLITHIASIS 37 0.0008
399 SKIN DISCOLOURATION 37 0.0008
400 THINKING ABNORMAL 15 0.0008
401 ANEURYSM 4 0.0008
402 INFUSION SITE EXTRAVASATION 5 0.0008
403 ARRHYTHMIA 38 0.0008
404 ERYTHEMA 164 0.0008
405 IMPAIRED HEALING 26 0.0008
406 CONTUSION 76 0.0008
407 DISCOMFORT 48 0.0008
408 COMMUNICATION DISORDER 3 0.0008
409 LIP SWELLING 26 0.0008
410 INITIAL INSOMNIA 8 0.0008
411 APHTHOUS ULCER 6 0.0008
412 INSOMNIA 206 0.0008
413 ELECTROCARDIOGRAM ABNORMAL 6 0.0008
414 FOOD CRAVING 4 0.0008
415 MYALGIA 129 0.0008
416 BLOOD IRON DECREASED 9 0.0008
417 HYPOKINESIA 11 0.0008
418 LOSS OF CONSCIOUSNESS 97 0.0008
419 NASAL DISCOMFORT 6 0.0008
420 SUICIDAL IDEATION 69 0.0008
421 UPPER LIMB FRACTURE 15 0.0008
422 EATING DISORDER 16 0.0008
423 NIGHTMARE 26 0.0008
424 FOOD POISONING 4 0.0007
425 FLANK PAIN 7 0.0007
426 DYSARTHRIA 28 0.0007
427 LIMB DISCOMFORT 23 0.0007
428 MYASTHENIA GRAVIS 6 0.0007
429 BRONCHIECTASIS 5 0.0007
430 BRUXISM 4 0.0007
431 ARTHRALGIA 308 0.0007
432 FOOT FRACTURE 14 0.0007
433 RASH 321 0.0007
434 BACK INJURY 8 0.0007
435 PALLOR 20 0.0007
436 HYDROCEPHALUS 4 0.0007
437 GASTROINTESTINAL PAIN 8 0.0007
438 ONYCHOCLASIS 5 0.0007
439 DEAFNESS UNILATERAL 4 0.0007
440 DRUG INEFFECTIVE 951 0.0007
441 VISION BLURRED 99 0.0007
442 EAR PAIN 14 0.0007
443 NERVE INJURY 8 0.0007
444 DYSSTASIA 21 0.0007
445 HEART RATE ABNORMAL 4 0.0007
446 PERIPHERAL SWELLING 110 0.0007
447 PRODUCT LEAKAGE 4 0.0007
448 OCULAR DISCOMFORT 8 0.0007
449 KNEE OPERATION 7 0.0007
450 DEPRESSION 161 0.0007
451 FEAR 19 0.0007
452 LYMPHADENOPATHY 25 0.0007
453 GENERALISED ERYTHEMA 4 0.0007
454 PRODUCT AVAILABILITY ISSUE 16 0.0007
455 SCAR 12 0.0007
456 LIMB INJURY 19 0.0007
457 BLOOD MAGNESIUM DECREASED 6 0.0007
458 MUSCLE STRAIN 6 0.0007
459 VISUAL FIELD DEFECT 5 0.0007
460 DERMATITIS BULLOUS 5 0.0007
461 SKIN WARM 4 0.0007
462 DYSPHEMIA 3 0.0007
463 PRODUCT PREPARATION ERROR 14 0.0007
464 TEMPERATURE INTOLERANCE 7 0.0007
465 POST PROCEDURAL COMPLICATION 13 0.0007
466 GLUCOSE TOLERANCE IMPAIRED 4 0.0007
467 SKIN HAEMORRHAGE 10 0.0007
468 CELLULITIS 34 0.0007
469 DYSPHAGIA 64 0.0007
470 MUSCULOSKELETAL STIFFNESS 59 0.0007
471 SINUS HEADACHE 4 0.0007
472 TENDERNESS 7 0.0007
473 THIRST 12 0.0007
474 ODYNOPHAGIA 4 0.0007
475 ACCIDENT 8 0.0007
476 FATIGUE 518 0.0007
477 RESTLESS LEGS SYNDROME 12 0.0007
478 TENSION 4 0.0007
479 SINUS DISORDER 13 0.0007
480 EAR DISORDER 3 0.0007
481 NAUSEA 518 0.0007
482 BOWEL MOVEMENT IRREGULARITY 5 0.0007
483 MENISCUS INJURY 4 0.0006
484 HEMIPARESIS 11 0.0006
485 RASH ERYTHEMATOUS 31 0.0006
486 TENDON RUPTURE 8 0.0006
487 ABNORMAL WEIGHT GAIN 8 0.0006
488 PRURITUS GENERALISED 14 0.0006
489 APHONIA 9 0.0006
490 PRE-EXISTING CONDITION IMPROVED 4 0.0006
491 SECRETION DISCHARGE 8 0.0006
492 SEASONAL ALLERGY 9 0.0006
493 COLITIS MICROSCOPIC 3 0.0006
494 DYSPHONIA 37 0.0006
495 TREMOR 105 0.0006
496 HEAD INJURY 20 0.0006
497 MALAISE 276 0.0006
498 SYRINGE ISSUE 11 0.0006
499 GINGIVAL PAIN 5 0.0006
500 GASTROINTESTINAL DISORDER 56 0.0006
501 ROTATOR CUFF SYNDROME 8 0.0006
502 ROAD TRAFFIC ACCIDENT 26 0.0006
503 COGNITIVE DISORDER 29 0.0006
504 DERMATITIS CONTACT 7 0.0006
505 BRADYPHRENIA 4 0.0006
506 FEELING COLD 17 0.0006
507 ABNORMAL FAECES 5 0.0006
508 DYSGRAPHIA 4 0.0006
509 FOOT OPERATION 3 0.0006
510 SARS-COV-2 TEST POSITIVE 8 0.0006
511 THERAPY CESSATION 31 0.0006
512 IMMUNODEFICIENCY 9 0.0006
513 ELECTROLYTE IMBALANCE 7 0.0006
514 APPLICATION SITE SWELLING 3 0.0006
515 BALANCE DISORDER 52 0.0006
516 EAR INFECTION 16 0.0006
517 OVARIAN CYST 6 0.0006
518 AMNESIA 39 0.0006
519 SEXUAL DYSFUNCTION 7 0.0006
520 GASTROOESOPHAGEAL REFLUX DISEASE 48 0.0006
521 NASAL CONGESTION 35 0.0006
522 BLOOD PRESSURE INCREASED 91 0.0006
523 MUSCLE SPASMS 109 0.0006
524 DRUG TOLERANCE 3 0.0006
525 ANGER 20 0.0006
526 EYELID PTOSIS 6 0.0006
527 MOTOR DYSFUNCTION 6 0.0006
528 SLUGGISHNESS 6 0.0006
529 EYE MOVEMENT DISORDER 4 0.0006
530 WRIST FRACTURE 7 0.0006
531 EMOTIONAL DISORDER 18 0.0006
532 DEVICE MECHANICAL ISSUE 8 0.0006
533 SKIN HYPERPIGMENTATION 5 0.0006
534 MENTAL IMPAIRMENT 14 0.0006
535 DIPLOPIA 15 0.0006
536 HYSTERECTOMY 5 0.0006
537 ORAL DISCOMFORT 8 0.0006
538 MENTAL DISORDER 25 0.0006
539 HUNGER 8 0.0006
540 AMENORRHOEA 10 0.0006
541 GROIN PAIN 5 0.0006
542 GRIP STRENGTH DECREASED 5 0.0006
543 MEMORY IMPAIRMENT 78 0.0006
544 IMMUNOSUPPRESSION 5 0.0006
545 SINUSITIS 58 0.0006
546 IRRITABILITY 34 0.0006
547 OBESITY 9 0.0006
548 RETCHING 12 0.0006
549 KIDNEY INFECTION 11 0.0006
550 HEREDITARY ANGIOEDEMA 6 0.0006
551 DYSPEPSIA 55 0.0006
552 ABDOMINAL PAIN UPPER 115 0.0006
553 LOSS OF LIBIDO 5 0.0006
554 ERYTHEMA OF EYELID 3 0.0006
555 MENSTRUATION DELAYED 6 0.0006
556 TONGUE DISORDER 4 0.0006
557 HYPERTENSION 117 0.0006
558 PAIN 338 0.0005
559 FAECES SOFT 4 0.0005
560 FAECALOMA 3 0.0005
561 INJECTION SITE NODULE 6 0.0005
562 PHOTOSENSITIVITY REACTION 9 0.0005
563 AUTISM SPECTRUM DISORDER 3 0.0005
564 TOOTH FRACTURE 6 0.0005
565 CHOKING SENSATION 3 0.0005
566 DENTAL CARIES 6 0.0005
567 NERVE COMPRESSION 5 0.0005
568 DRY EYE 27 0.0005
569 RASH GENERALISED 14 0.0005
570 BLINDNESS 22 0.0005
571 SUNBURN 4 0.0005
572 RASH PAPULAR 12 0.0005
573 APPENDICITIS 5 0.0005
574 TRANSIENT ISCHAEMIC ATTACK 18 0.0005
575 CEREBROVASCULAR ACCIDENT 90 0.0005
576 BREAST TENDERNESS 4 0.0005
577 HEART RATE IRREGULAR 12 0.0005
578 LACRIMATION INCREASED 16 0.0005
579 PAIN IN JAW 15 0.0005
580 GASTRIC ULCER 10 0.0005
581 SCAB 6 0.0005
582 PAIN IN EXTREMITY 155 0.0005
583 AORTIC ANEURYSM 4 0.0005
584 FEELING JITTERY 10 0.0005
585 SLEEP DISORDER 37 0.0005
586 SLEEP APNOEA SYNDROME 10 0.0005
587 MENSTRUATION IRREGULAR 14 0.0005
588 DEVICE PHYSICAL PROPERTY ISSUE 4 0.0005
589 PARANOIA 9 0.0005
590 QUALITY OF LIFE DECREASED 7 0.0005
591 AFFECT LABILITY 5 0.0005
592 THERAPY INTERRUPTED 37 0.0005
593 HERNIA 10 0.0005
594 VASCULITIS 6 0.0005
595 MOOD ALTERED 14 0.0005
596 VITAMIN D DEFICIENCY 5 0.0005
597 VIRAL INFECTION 17 0.0005
598 GASTROINTESTINAL INFLAMMATION 4 0.0005
599 MULTIPLE ALLERGIES 4 0.0005
600 NEOPLASM MALIGNANT 34 0.0005
601 AFFECTIVE DISORDER 4 0.0005
602 BRADYKINESIA 3 0.0005
603 SYSTEMIC LUPUS ERYTHEMATOSUS 18 0.0005
604 ABDOMINAL DISCOMFORT 85 0.0005
605 BLADDER DISORDER 5 0.0005
606 MULTIPLE SCLEROSIS 24 0.0005
607 MASS 7 0.0005
608 SENSORY DISTURBANCE 8 0.0005
609 POOR QUALITY DEVICE USED 5 0.0005
610 STENT PLACEMENT 4 0.0005
611 BURSITIS 6 0.0005
612 NOCTURIA 6 0.0005
613 DRY MOUTH 40 0.0005
614 DRY THROAT 5 0.0005
615 EPILEPSY 15 0.0005
616 HYPOACUSIS 21 0.0005
617 TACHYCARDIA 43 0.0005
618 LOWER RESPIRATORY TRACT INFECTION 22 0.0005
619 PHARYNGITIS 6 0.0005
620 CYST 6 0.0005
621 POOR VENOUS ACCESS 5 0.0005
622 MUSCLE INJURY 4 0.0005
623 BACK PAIN 112 0.0005
624 BLOOD PRESSURE DECREASED 32 0.0005
625 BLISTER 27 0.0005
626 URINARY RETENTION 16 0.0005
627 DISORIENTATION 19 0.0005
628 PETECHIAE 5 0.0005
629 BONE PAIN 28 0.0005
630 PRODUCT USE IN UNAPPROVED INDICATION 118 0.0005
631 MUSCULAR WEAKNESS 54 0.0005
632 SENSATION OF FOREIGN BODY 4 0.0005
633 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 8 0.0005
634 HERPES ZOSTER 27 0.0005
635 LOWER LIMB FRACTURE 9 0.0005
636 LIVER FUNCTION TEST INCREASED 10 0.0005
637 HYPERHIDROSIS 60 0.0005
638 WOUND 13 0.0005
639 RESTLESSNESS 17 0.0005
640 HOT FLUSH 35 0.0005
641 DECREASED ACTIVITY 5 0.0005
642 DYSPNOEA 262 0.0005
643 INCORRECT PRODUCT ADMINISTRATION DURATION 10 0.0005
644 ASTHMA 52 0.0005
645 BIPOLAR DISORDER 5 0.0005
646 SKIN LACERATION 5 0.0005
647 BLOOD PRESSURE FLUCTUATION 11 0.0005
648 RASH MACULAR 16 0.0005
649 URINE OUTPUT DECREASED 4 0.0005
650 JOINT STIFFNESS 12 0.0005
651 EYE SWELLING 17 0.0005
652 GASTRITIS 12 0.0005
653 SPINAL OSTEOARTHRITIS 4 0.0005
654 OROPHARYNGEAL PAIN 42 0.0005
655 FLUSHING 46 0.0005
656 ANKLE FRACTURE 7 0.0005
657 SOMNOLENCE 91 0.0005
658 INFLUENZA 50 0.0004
659 PRODUCT PHYSICAL ISSUE 9 0.0004
660 SNEEZING 10 0.0004
661 PAIN OF SKIN 12 0.0004
662 THERAPY NON-RESPONDER 20 0.0004
663 FREQUENT BOWEL MOVEMENTS 12 0.0004
664 SINUS CONGESTION 6 0.0004
665 DEVICE BREAKAGE 18 0.0004
666 GASTROENTERITIS VIRAL 8 0.0004
667 VOMITING 208 0.0004
668 ABNORMAL LOSS OF WEIGHT 3 0.0004
669 CHOLECYSTECTOMY 5 0.0004
670 SKIN LESION 12 0.0004
671 PNEUMONIA BACTERIAL 4 0.0004
672 RETINAL DETACHMENT 4 0.0004
673 ABDOMINAL PAIN LOWER 11 0.0004
674 INCREASED TENDENCY TO BRUISE 4 0.0004
675 NIGHT SWEATS 14 0.0004
676 DROOLING 3 0.0004
677 IRON DEFICIENCY ANAEMIA 4 0.0004
678 BACK DISORDER 7 0.0004
679 DEFAECATION URGENCY 3 0.0004
680 APPLICATION SITE REACTION 3 0.0004
681 DEVICE OCCLUSION 6 0.0004
682 INFLAMMATION 22 0.0004
683 FRACTURE 8 0.0004
684 TREATMENT FAILURE 35 0.0004
685 SPINAL DISORDER 4 0.0004
686 JOINT INJURY 9 0.0004
687 ATAXIA 5 0.0004
688 DEAFNESS 11 0.0004
689 CEREBRAL HAEMORRHAGE 15 0.0004
690 FAECES DISCOLOURED 9 0.0004
691 INJECTION SITE HAEMATOMA 6 0.0004
692 GASTROENTERITIS 6 0.0004
693 HAEMORRHOIDS 8 0.0004
694 CHOKING 8 0.0004
695 ORAL HERPES 8 0.0004
696 ACUTE MYOCARDIAL INFARCTION 12 0.0004
697 ANGIOEDEMA 18 0.0004
698 URINARY INCONTINENCE 12 0.0004
699 ARTHROPOD BITE 3 0.0004
700 LIGAMENT SPRAIN 4 0.0004
701 BLOOD PRESSURE ABNORMAL 8 0.0004
702 ILEUS 5 0.0004
703 HYPOTONIA 4 0.0004
704 DEEP VEIN THROMBOSIS 26 0.0004
705 FALL 133 0.0004
706 COLITIS 15 0.0004
707 URINARY TRACT INFECTION 67 0.0004
708 SUBARACHNOID HAEMORRHAGE 4 0.0004
709 BRONCHITIS 29 0.0004
710 EUPHORIC MOOD 4 0.0004
711 MOBILITY DECREASED 28 0.0004
712 ATRIOVENTRICULAR BLOCK 3 0.0004
713 ASTHENIA 145 0.0004
714 PELVIC PAIN 7 0.0004
715 NODULE 5 0.0004
716 LETHARGY 22 0.0004
717 EYE IRRITATION 22 0.0004
718 CYANOSIS 6 0.0004
719 TOOTH INFECTION 5 0.0004
720 CONFUSIONAL STATE 61 0.0004
721 RENAL PAIN 4 0.0004
722 EYE HAEMORRHAGE 5 0.0004
723 BLOOD DISORDER 3 0.0004
724 BODY HEIGHT DECREASED 4 0.0004
725 ABDOMINAL PAIN 87 0.0004
726 MOVEMENT DISORDER 12 0.0004
727 THROMBOSIS 30 0.0004
728 HOSPITALISATION 57 0.0004
729 PHARYNGITIS STREPTOCOCCAL 4 0.0004
730 DYSKINESIA 15 0.0004
731 PRODUCT DISPENSING ERROR 8 0.0004
732 CHILLS 43 0.0004
733 INCREASED APPETITE 7 0.0004
734 HICCUPS 3 0.0004
735 EYE DISORDER 12 0.0004
736 EMBOLISM 3 0.0004
737 DIVERTICULITIS 10 0.0004
738 EOSINOPHIL COUNT INCREASED 3 0.0004
739 TOOTH DISORDER 8 0.0004
740 SKIN FISSURES 7 0.0004
741 WITHDRAWAL SYNDROME 15 0.0004
742 EYE PRURITUS 12 0.0004
743 RHINORRHOEA 23 0.0004
744 NASOPHARYNGITIS 65 0.0004
745 NERVOUS SYSTEM DISORDER 11 0.0004
746 WEIGHT DECREASED 98 0.0004
747 BRONCHOSPASM 5 0.0004
748 NEOPLASM 4 0.0003
749 COUGH 97 0.0003
750 CYSTITIS 11 0.0003
751 GAIT DISTURBANCE 66 0.0003
752 BLOOD CALCIUM INCREASED 3 0.0003
753 HEART RATE DECREASED 12 0.0003
754 AGITATION 25 0.0003
755 ISCHAEMIC STROKE 6 0.0003
756 PULMONARY MASS 5 0.0003
757 FLATULENCE 19 0.0003
758 SKIN BURNING SENSATION 24 0.0003
759 ANAL INCONTINENCE 3 0.0003
760 THYROID CANCER 4 0.0003
761 SKIN EXFOLIATION 28 0.0003
762 HALLUCINATION 25 0.0003
763 LOCALISED INFECTION 8 0.0003
764 ECONOMIC PROBLEM 5 0.0003
765 SKIN DISORDER 11 0.0003
766 EXOSTOSIS 3 0.0003
767 HIP ARTHROPLASTY 5 0.0003
768 BLOOD THYROID STIMULATING HORMONE INCREASED 3 0.0003
769 UPPER RESPIRATORY TRACT INFECTION 15 0.0003
770 GENERALISED OEDEMA 4 0.0003
771 DYSGEUSIA 24 0.0003
772 TENDONITIS 5 0.0003
773 VAGINAL HAEMORRHAGE 14 0.0003
774 DEMENTIA 9 0.0003
775 ERYTHEMA MULTIFORME 3 0.0003
776 THERAPY PARTIAL RESPONDER 5 0.0003
777 BASAL CELL CARCINOMA 5 0.0003
778 ARTERIOSCLEROSIS 3 0.0003
779 INTESTINAL OBSTRUCTION 12 0.0003
780 BLOOD SODIUM DECREASED 6 0.0003
781 INFECTION 46 0.0003
782 JOINT SWELLING 38 0.0003
783 SCIATICA 5 0.0003
784 ABSCESS 5 0.0003
785 GLOSSODYNIA 7 0.0003
786 ERECTILE DYSFUNCTION 8 0.0003
787 DIZZINESS POSTURAL 3 0.0003
788 HYPOTENSION 61 0.0003
789 ORAL CANDIDIASIS 4 0.0003
790 ACNE 23 0.0003
791 STAPHYLOCOCCAL INFECTION 10 0.0003
792 GENERALISED TONIC-CLONIC SEIZURE 5 0.0003
793 PSYCHOMOTOR HYPERACTIVITY 5 0.0003
794 BLOOD POTASSIUM DECREASED 9 0.0003
795 HAIR TEXTURE ABNORMAL 4 0.0003
796 FACE OEDEMA 5 0.0003
797 BODY TEMPERATURE INCREASED 6 0.0003
798 ARTHRITIS 23 0.0003
799 DYSPNOEA EXERTIONAL 11 0.0003
800 RIB FRACTURE 6 0.0003
801 HYPOGLYCAEMIA 14 0.0003
802 PROCEDURAL PAIN 8 0.0003
803 ORTHOSTATIC HYPOTENSION 5 0.0003
804 COORDINATION ABNORMAL 4 0.0003
805 WHEEZING 17 0.0003
806 HALLUCINATION, VISUAL 6 0.0003
807 PULMONARY EMBOLISM 27 0.0003
808 INCONTINENCE 3 0.0003
809 BLINDNESS UNILATERAL 4 0.0003
810 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
811 FOETAL EXPOSURE DURING PREGNANCY 23 0.0003
812 MOOD SWINGS 9 0.0003
813 HYPOTHYROIDISM 9 0.0003
814 BREAST PAIN 3 0.0003
815 EPISTAXIS 21 0.0003
816 ABNORMAL BEHAVIOUR 11 0.0003
817 DRY SKIN 37 0.0003
818 OEDEMA 15 0.0003
819 HYPERTHYROIDISM 4 0.0003
820 COMPLICATION ASSOCIATED WITH DEVICE 4 0.0003
821 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
822 SKIN ULCER 7 0.0003
823 STEVENS-JOHNSON SYNDROME 6 0.0003
824 HYPERTENSIVE CRISIS 3 0.0003
825 DIARRHOEA 174 0.0003
826 OSTEOPOROSIS 11 0.0003
827 SEDATION 7 0.0003
828 BLOOD CALCIUM DECREASED 3 0.0003
829 UNEVALUABLE EVENT 20 0.0003
830 WHITE BLOOD CELL COUNT INCREASED 10 0.0003
831 PYREXIA 90 0.0003
832 PHARYNGEAL OEDEMA 4 0.0003
833 ERUCTATION 5 0.0003
834 CAESAREAN SECTION 3 0.0003
835 TREATMENT NONCOMPLIANCE 14 0.0003
836 FLUID RETENTION 13 0.0003
837 HAEMATOCHEZIA 14 0.0003
838 CONDITION AGGRAVATED 77 0.0003
839 OCULAR HYPERAEMIA 12 0.0003
840 NEUROPATHY PERIPHERAL 24 0.0003
841 ARTHROPATHY 14 0.0003
842 HALLUCINATION, AUDITORY 4 0.0003
843 SPINAL FRACTURE 5 0.0002
844 DRUG INTOLERANCE 24 0.0002
845 BREAST CANCER 23 0.0002
846 LUNG DISORDER 12 0.0002
847 MANIA 4 0.0002
848 DECREASED APPETITE 56 0.0002
849 HAEMORRHAGE 25 0.0002
850 DERMATITIS 5 0.0002
851 CARDIAC DISORDER 22 0.0002
852 CIRCULATORY COLLAPSE 4 0.0002
853 HEPATIC ENZYME INCREASED 16 0.0002
854 RECTAL HAEMORRHAGE 10 0.0002
855 DELIRIUM 8 0.0002
856 MUSCULOSKELETAL PAIN 12 0.0002
857 DEPRESSED LEVEL OF CONSCIOUSNESS 9 0.0002
858 APPLICATION SITE PAIN 5 0.0002
859 ACUTE RESPIRATORY DISTRESS SYNDROME 4 0.0002
860 COLITIS ULCERATIVE 10 0.0002
861 MYOCARDIAL INFARCTION 39 0.0002
862 APPLICATION SITE PRURITUS 5 0.0002
863 RHEUMATOID ARTHRITIS 25 0.0002
864 HYPERGLYCAEMIA 8 0.0002
865 SKIN IRRITATION 10 0.0002
866 HIP FRACTURE 7 0.0002
867 BLOOD GLUCOSE ABNORMAL 4 0.0002
868 POLLAKIURIA 9 0.0002
869 CONJUNCTIVITIS 4 0.0002
870 BACTERIAL INFECTION 4 0.0002
871 CARPAL TUNNEL SYNDROME 3 0.0002
872 OXYGEN SATURATION DECREASED 12 0.0002
873 BLOOD TEST ABNORMAL 3 0.0002
874 OSTEOARTHRITIS 9 0.0002
875 BLOOD URINE PRESENT 4 0.0002
876 ECZEMA 11 0.0002
877 EXPOSURE DURING PREGNANCY 13 0.0002
878 APATHY 3 0.0002
879 BLOOD PRESSURE SYSTOLIC INCREASED 4 0.0002
880 HAEMORRHAGE INTRACRANIAL 3 0.0002
881 RESPIRATORY DISORDER 6 0.0002
882 PREGNANCY 4 0.0002
883 PRODUCT DOSE OMISSION 13 0.0002
884 PNEUMONIA 64 0.0002
885 PRODUCT COMPLAINT 5 0.0002
886 DEHYDRATION 26 0.0002
887 DEVICE RELATED INFECTION 3 0.0002
888 DELUSION 3 0.0002
889 HAEMATOMA 5 0.0002
890 TOOTH LOSS 4 0.0002
891 DRUG EFFECT INCOMPLETE 7 0.0002
892 C-REACTIVE PROTEIN INCREASED 7 0.0002
893 RESPIRATORY TRACT INFECTION 5 0.0002
894 OFF LABEL USE 168 0.0002
895 PRODUCT SUBSTITUTION ISSUE 11 0.0002
896 KNEE ARTHROPLASTY 4 0.0002
897 BREAST CANCER FEMALE 5 0.0002
898 ATRIAL FIBRILLATION 18 0.0002
899 INTENTIONAL PRODUCT USE ISSUE 16 0.0002
900 ILL-DEFINED DISORDER 11 0.0002
901 INFUSION RELATED REACTION 12 0.0002
902 SEPSIS 20 0.0002
903 HAEMOPTYSIS 5 0.0002
904 UNDERDOSE 13 0.0002
905 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 6 0.0002
906 CHROMATURIA 4 0.0002
907 GASTRIC DISORDER 6 0.0002
908 BLOOD CREATINE PHOSPHOKINASE INCREASED 5 0.0002
909 OEDEMA PERIPHERAL 21 0.0002
910 RENAL DISORDER 8 0.0002
911 DERMATITIS ATOPIC 9 0.0002
912 PANCREATITIS 9 0.0002
913 GALLBLADDER DISORDER 3 0.0002
914 GOUT 3 0.0002
915 BLOOD GLUCOSE DECREASED 8 0.0002
916 PREMATURE BABY 5 0.0002
917 COMPLICATION OF DEVICE REMOVAL 3 0.0002
918 GENERAL PHYSICAL HEALTH DETERIORATION 19 0.0002
919 ACCIDENTAL OVERDOSE 6 0.0002
920 CEREBRAL INFARCTION 4 0.0002
921 MULTIPLE SCLEROSIS RELAPSE 11 0.0002
922 INTENTIONAL PRODUCT MISUSE 14 0.0002
923 LIVER DISORDER 7 0.0002
924 DYSTONIA 3 0.0002
925 PRODUCT QUALITY ISSUE 21 0.0002
926 APPLICATION SITE ERYTHEMA 4 0.0002
927 DRUG INTERACTION 24 0.0002
928 CATARACT 9 0.0002
929 BRADYCARDIA 8 0.0002
930 EXPIRED PRODUCT ADMINISTERED 5 0.0002
931 TYPE 2 DIABETES MELLITUS 5 0.0001
932 STOMATITIS 9 0.0001
933 PSORIATIC ARTHROPATHY 6 0.0001
934 COMA 7 0.0001
935 ALANINE AMINOTRANSFERASE INCREASED 9 0.0001
936 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 8 0.0001
937 RESPIRATORY DISTRESS 4 0.0001
938 DIABETES MELLITUS 11 0.0001
939 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
940 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 7 0.0001
941 CONTRAINDICATED PRODUCT ADMINISTERED 4 0.0001
942 SUICIDE ATTEMPT 8 0.0001
943 ASPARTATE AMINOTRANSFERASE INCREASED 7 0.0001
944 FEMUR FRACTURE 4 0.0001
945 BLOOD CHOLESTEROL INCREASED 6 0.0001
946 MEDICATION ERROR 7 0.0001
947 EXTRA DOSE ADMINISTERED 5 0.0001
948 ENCEPHALOPATHY 3 0.0001
949 CHOLELITHIASIS 4 0.0001
950 AGEUSIA 3 0.0001
951 FUNGAL INFECTION 4 0.0001
952 AGGRESSION 6 0.0001
953 HYPOPHAGIA 3 0.0001
954 HAEMATURIA 4 0.0001
955 THERAPEUTIC RESPONSE DECREASED 7 0.0001
956 DEATH 97 0.0001
957 CARDIAC FAILURE CONGESTIVE 9 0.0001
958 BLOOD BILIRUBIN INCREASED 3 0.0001
959 WHITE BLOOD CELL COUNT DECREASED 12 0.0001
960 PSORIASIS 14 0.0001
961 BLOOD GLUCOSE INCREASED 20 0.0001
962 PRODUCTIVE COUGH 5 0.0001
963 EMOTIONAL DISTRESS 12 0.0001
964 CORONARY ARTERY DISEASE 3 0.0001
965 NEUTROPHIL COUNT DECREASED 4 0.0001
966 HAEMOGLOBIN DECREASED 10 0.0001
967 DRUG EFFECT DECREASED 5 0.0001
968 BLOOD CREATININE INCREASED 6 0.0001
969 CARDIAC FAILURE 7 0.0001
970 DISEASE RECURRENCE 4 0.0001
971 DYSURIA 3 0.0001
972 NO ADVERSE EVENT 13 0.0001
973 RENAL IMPAIRMENT 6 0.0001
974 INJURY 5 0.0001
975 DEVICE DISLOCATION 3 0.0001
976 DRUG DEPENDENCE 11 0.0001
977 CHRONIC KIDNEY DISEASE 5 0.0001
978 THROMBOCYTOPENIA 7 0.0001
979 CARDIAC ARREST 5 0.0001
980 INTENTIONAL OVERDOSE 3 0.0000
981 DRUG WITHDRAWAL SYNDROME 4 0.0000
982 ANAEMIA 8 0.0000
983 PLATELET COUNT DECREASED 4 0.0000
984 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
985 OVERDOSE 6 0.0000